Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab that empowers every person by providing access to accurate, clinical testing when and where it matters most, has appointed Benjamin Lejfer as its new Director of Digital Health.
Lejfer brings a decade of strategic experience propelling business growth and helping some of the world’s leading brands create great customer experiences; he has brought this knowledge to IHD where he will work to partner with digital health brands to make clinically accurate diagnostics testing available for their patients at-home. .
In his new role, Lejfer will lead IHD’s Diagnostics as-a-Service business unit where he will be responsible for growth, building partnerships with digital brands, and new channels, while ensuring customer success. IHD recently launched its Diagnostics as a Service (DaaS) platform, giving brands the ability to provide their patients with access to at-home healthcare at any time and anywhere.
“We are thrilled to welcome Ben to our team and leverage his deep expertise in software and digital health to further elevate and grow our company,” said IHD CEO and Co-Founder David White. “Ben’s ability to lead and collaborate with the digital health ecosystem will help drive our company forward. We look forward to collaborating with Ben to extend our mission of empowering people with gold standard clinical testing wherever they are beyond traditional channels and further into the digital health space.”
Lejfer joins IHD with a background in helping companies grow and scale, most recently with Contentsquare, where he drove global partnerships and strategy, as the company grew from a start up to over 750 employees. His experience fueling company growth will add a strategic lens furthering IHD’s mission of empowering every person to take control of their health by providing easy access to care.
About Innovative Health Diagnostics
Innovative Health Diagnostics (IHD) empowers every person by providing access to accurate, clinical testing, when and where it matters most. IHD services also include fertility and in vitro fertilization (IVF) testing; FDA donor testing for families completing surrogacies; and COVID-19 polymerase chain reaction (PCR) and antibody testing.
A nimble, collaborative partner, IHD operates with the patient in mind at all times, offering the highest standards of integrity and service, quick turnaround times, and affordability. To learn more, please visit ihdlab.com or follow us on LinkedIn, Twitter, Facebook and Instagram.